Sinopharm Group Co. Ltd. (SHTDY)
USD 13.79
(0.0%)
USD 13.79
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 596.56 Billion | 552.14 Billion | 521.05 Billion | 456.41 Billion | 425.27 Billion | 344.52 Billion |
| Cost of Revenue | 548.05 Billion | 504.71 Billion | 477 Billion | 416.09 Billion | 387.74 Billion | 313.29 Billion |
| Gross Profit | 48.51 Billion | 47.43 Billion | 44.05 Billion | 40.32 Billion | 37.53 Billion | 31.22 Billion |
| Operating Expenses | 28.3 Billion | 24.22 Billion | 22.6 Billion | 20.53 Billion | 19.02 Billion | 15.47 Billion |
| Selling, General and Administrative Expenses | 26.77 Billion | 24.9 Billion | 23.19 Billion | 21.19 Billion | 19.46 Billion | 15.88 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 1.52 Billion | 29.04 Million | 56.4 Million | 12.47 Million | 467 Thousand | 3.58 Million |
| Cost and Expenses | 576.36 Billion | 528.94 Billion | 499.6 Billion | 436.63 Billion | 406.76 Billion | 328.77 Billion |
| Operating Income | 20.2 Billion | 20.6 Billion | 19.71 Billion | 17.75 Billion | 16.13 Billion | 15.39 Billion |
| Interest Expense | 2.95 Billion | 3.52 Billion | 3.75 Billion | 3.42 Billion | 3.44 Billion | 4.15 Billion |
| Income Tax Expense | 4.5 Billion | 4.21 Billion | 3.93 Billion | 3.5 Billion | 3.13 Billion | 2.8 Billion |
| Earnings before Tax | 19.51 Billion | 18.56 Billion | 17 Billion | 15.59 Billion | 13.75 Billion | 12.2 Billion |
| Net Income | 9.05 Billion | 8.52 Billion | 7.75 Billion | 7.18 Billion | 6.25 Billion | 5.83 Billion |
| Earnings Per Share Basic | 2.90 | 2.72 | 2.49 | 2.18 | 2.04 | 1.78 |
| Earnings Per Share Diluted | 2.90 | 2.72 | 2.49 | 2.18 | 2.04 | 1.79 |
| Weighted Average Shares Outstanding | 3.11 Billion | 3.13 Billion | 3.12 Billion | 3.3 Billion | 3.06 Billion | 3.27 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3.11 Billion | 3.13 Billion | 3.12 Billion | 3.3 Billion | 3.05 Billion | 3.26 Billion |
| Gross Margin | 0.08 | 0.09 | 0.08 | 0.09 | 0.09 | 0.09 |
| EBIT Margin | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| Profit Margin | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 | 0.02 |
| EBITDA | 26.89 Billion | 26.24 Billion | 24.68 Billion | 22.61 Billion | 20.31 Billion | 16.67 Billion |
| Earnings Before Tax Margin | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 147.46 Billion | 147.26 Billion | 150.64 Billion | 596.56 Billion | 144.96 Billion | 155.43 Billion |
| Cost of Revenue | 136.09 Billion | 136.69 Billion | 137.33 Billion | 548.05 Billion | 133.04 Billion | 143.1 Billion |
| Gross Profit | 11.36 Billion | 10.57 Billion | 13.31 Billion | 48.51 Billion | 11.92 Billion | 12.32 Billion |
| Operating Expenses | 6.24 Billion | 7.17 Billion | 6.48 Billion | 26.23 Billion | 417.63 Billion | 6.17 Billion |
| Selling, General and Administrative Expenses | 6.87 Billion | 6.84 Billion | 7.06 Billion | - | 5.72 Billion | 7.05 Billion |
| Research and Development Expenses | 71.13 Million | 71.13 Million | 260.77 Million | - | 260.77 Million | 95.95 Million |
| Other Expenses | -702.85 Million | 566.23 Million | - | -41.8 Million | 9.35 Million | - |
| Cost and Expenses | 142.33 Billion | 143.86 Billion | 143.81 Billion | 574.29 Billion | 139.95 Billion | 149.28 Billion |
| Operating Income | 5.12 Billion | 3.38 Billion | 7.76 Billion | 20.2 Billion | 3.46 Billion | 5.81 Billion |
| Interest Expense | - | - | - | 2.95 Billion | 366.98 Million | - |
| Income Tax Expense | 972.42 Million | 724.84 Million | 1.54 Billion | 4.5 Billion | 987.09 Million | 1.14 Billion |
| Earnings before Tax | 4.47 Billion | 3.12 Billion | 6.48 Billion | 19.51 Billion | 4.16 Billion | 5.22 Billion |
| Net Income | 2.28 Billion | 1.42 Billion | 2.95 Billion | 9.05 Billion | 1.99 Billion | 2.51 Billion |
| Earnings Per Share Basic | 0.73 | 0.46 | 0.94 | - | 0.64 | 0.81 |
| Earnings Per Share Diluted | 0.73 | 0.46 | 0.94 | - | 0.64 | 0.81 |
| Weighted Average Shares Outstanding | 3.12 Billion | 3.11 Billion | 3.11 Billion | 624.13 Million | 3.11 Billion | 3.11 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3.12 Billion | 3.11 Billion | 3.11 Billion | 624.13 Million | 3.11 Billion | 3.11 Billion |
| Gross Margin | 0.08 | 0.07 | 0.09 | 0.08 | 0.08 | 0.08 |
| EBIT Margin | 0.04 | 0.03 | 0.06 | - | 0.03 | 0.04 |
| Profit Margin | 0.02 | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 |
| EBITDA | 5.56 Billion | 3.9 Billion | 8.28 Billion | - | 4.3 Billion | 6.35 Billion |
| Earnings Before Tax Margin | 0.03 | 0.02 | 0.05 | 0.03 | 0.02 | 0.04 |
RVLY
1965
ENQUF
SBGSY
RSNVF
DIL